GOVX Corporate Update soon | 10X Upside Potential Analyst Rating

NASDAQ:GOVX   GeoVax Labs, Inc
GOVX GeoVax Labs is a biotechnology company developing immunotherapies and vaccines against infectious diseases and cancer.
GeoVax Labs will report Q1 2022 financial results on April 27.

Jason McCarthy from Maxim Group has a $10.00 price target for GOVX .
The stock is now $1.01.
Market Cap of only 7.23Mil.

This is a 4X upside potential short term stock in my opinion.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.